Maytansinol butyrate(CAS: 66547-09-9)

Maytansinol butyrate (CAS: 66547-09-9) falls under the regulatory frameworks of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations, and FDA/EPA guidelines for pharmaceutical and toxicological assessments. This compound requires compliance with specific handling, storage, and disposal protocols to ensure safety and environmental protection.

In synthesis, alternatives to Maytansinol butyrate include other conjugation strategies such as maytansinol isothiocyanate and maytansinol pyrrolidinones. These alternatives offer variations in reactivity and can be used depending on the specific application and desired properties of the resulting drug conjugate.

The market and research trends for Maytansinol butyrate (CAS: 66547-09-9) are driven by its potential as a targeted therapy in cancer treatment. There is ongoing interest in optimizing its delivery systems and exploring its use in combination with other drugs. Recent research focuses on enhancing therapeutic efficacy and reducing side effects, aligning with the growing trend towards personalized medicine.

Waste containing Maytansinol butyrate (CAS: 66547-09-9) should be collected in appropriate containers and disposed of through professional waste disposal services that comply with local regulations. Incineration is a common method of disposal, but it must be conducted in a controlled environment to prevent environmental contamination. Proper handling and disposal are crucial to ensure safety and regulatory compliance.